Announce

dentist

The Dentist Entrepreneur Organization and Share Moving Media Announce Joint Venture to Publish DSO-focused Dental Trade Magazine

The Dentist Entrepreneur Organization (DEO) is committed to providing emerging dental group leaders access to the connections, education, and resources they need to grow. So, The DEO is excited to announce its joint venture with Share Moving Media to form DEO Media, LLC, publisher of Efficiency In Group Practice Magazine, a resource for dentist entrepreneurs and DSO leaders.

PORTLAND, Ore. (PRWEB) December 03, 2020

The Dentist Entrepreneur Organization (The DEO) of Portland, Oregon and Share Moving Media of Lawrenceville, Georgia announce the formation of a new entity called DEO Media, LLC, a joint venture between the two organizations to publish Efficiency in Group Practice, a bi-monthly dental trade magazine focused on DSOs (dental service organizations) and group dentistry.

“We’re extremely excited to give emerging dental group leaders even more access to the people, education, and resources they need to grow,” said Jacob Puhl, CEO of The DEO. “This partnership further enables us to continue our mission to help dentist entrepreneurs and their executives fulfill their visions. We hope to have a continued positive impact on the dental community.”

Efficiency In Group Practice provides an informational and educational link between manufacturers, distributors, service providers, and dental group practices. Each issue of Efficiency covers emerging trends in dentistry, and provides content to enable group practices to capitalize on their distinct strengths and differences to reach new heights of efficiency and become more profitable.

“This new partnership positions Efficiency in Group Practice with the leadership and direction so dearly needed for a publication to thrive in these dynamic times,” said Share Moving Media CEO John Pritchard. “Now more than ever, dental group practices need insight, understanding and community to grow their practices. We are excited to partner with Jacob Puhl and the entire DEO team to help provide just that!”

Under the partnership, The DEO and Share Moving Media will collaborate on editorial, sales, marketing and distribution of the industry-leading publication. Jacob Puhl, partner and CEO of the Dentist Entrepreneur Organization, will be Efficiency’s publisher.

The first issue from DEO Media, LLC will be the January-February 2021 edition of Efficiency In Group Practice.

About

The Dentist Entrepreneur Organization© (DEO) provides a context, a professional resource, and a peer-to-peer network within a well-managed organizational structure. For more information, visit https://deodentalgroup.com/.

Share Moving Media is a leading publishing and content company providing information, communication and educational services to providers, manufacturers and distributors involved in the business of healthcare. For more information, visit https://sharemovingmedia.com/.

For more information on Efficiency in Group Practice, visit https://www.dentalgrouppractice.com/.

For the original version on PRWeb visit: https://www.prweb.com/releases/the_dentist_entrepreneur_organization_and_share_moving_media_announce_joint_venture_to_publish_dso_focused_dental_trade_magazine/prweb17583024.htm

Source Article

Read More
medicine

Gulf Medical University College of Medicine and ScholarRx Announce Medical Education Partnership

LOUISVILLE, Ky., Dec. 2, 2020 /PRNewswire/ — Today the Gulf Medical University College of Medicine (GMU) and ScholarRx announced a collaboration to further the College’s educational mission. GMU has adopted the Rx Bricks online service from ScholarRx, a revolutionary digital learning platform that supports the curriculum and enhances pre-clinical instruction.

Prof. Hossam Hamdy, Chancellor, Gulf Medical University states, “Gulf Medical University’s partnership with ScholarRx ensures that the content of the medical curriculum is benchmarked with similar top U.S. medical colleges using the same program. The Rx Bricks of ScholarRx provide our students with up-to-date medical knowledge through educationally sound courses delivered by expert faculty. As a leading medical university in the Middle East, Gulf Medical University will contribute to the continuous development of ScholarRx by integrating its Virtual Patient Learning (VPL) technology in the Rx Bricks, conducting research, and evaluating the educational impact of ScholarRx.  I am sure our students and faculty will appreciate the value of ScholarRx.” 

GMU uses the innovative Rx Bricks digital learning platform from ScholarRx to better engage and align medical students with the curriculum. This has become especially important as more learning is taking place online. With this new set of resources, faculty teaching GMU students can:

  • Assign specific Rx Bricks through their learning management system
  • Use question banks accompanying the Rx Bricks for both formative and summative assessments, and
  • Provide foundational support to their virtual patient learning sessions.

“Collaboration with ScholarRx has enriched and added value to our existing online learning resources, as the College of Medicine has been able to seamlessly integrate the Rx Bricks in the medical curriculum. Faculty and students alike have embraced it with ease due to the user-friendly nature of the resource,” said Prof. Manda Venkatramana, Vice-Chancellor Academics and Dean, College of Medicine at Gulf Medical University.

“GMU has developed into a leading institution for medical education in the Middle East under the visionary leadership of Chancellor Hamdy and Vice-Chancellor Manda,” said Dr. Tao Le, Founder and CEO of ScholarRx. “We are pleased to support their remarkable work in digital curricular innovation.”

About Gulf Medical University College of Medicine
The vision of the university is to be a leading international academic healthcare institution through the integration of quality health professions education, research, healthcare, and social accountability for sustainable community development. The College of Medicine, in existence since 1998, has managed to not only impart quality medical education, but has also created a network of healthcare services, a conducive research milieu, and developed unique related avenues for professional development, policy, and leadership to meet the healthcare needs of the nation and the region.

About ScholarRx
ScholarRx is a mission-driven education organization currently serving over 150,000 medical students and physician learners annually.  ScholarRx has developed a revolutionary componentized, multi-competency curricular platform that empowers medical schools and their faculty to rapidly develop high-quality education experiences, even in resource-poor environments.

SOURCE ScholarRx

Related Links

http://www.scholarrx.com

Source Article

Read More
medicine

Gain Therapeutics and University of Maryland School of Medicine Announce Research Collaboration

BETHESDA, Md. and BALTIMORE, Nov. 30, 2020 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (“Gain”), today announced a research collaboration with the University of Maryland School of Medicine (UMSOM), to investigate Gain’s structurally targeted allosteric regulators (STARs) in cellular models of neuronopathic Gaucher disease (nGD) and Parkinson’s disease (PD). STARs are proprietary small molecules targeting novel allosteric binding sites on enzymes. These small molecule drug candidates are designed to cross the blood brain barrier and penetrate other hard to treat organs such as bone and cartilage, stabilize the effective enzyme to restore function and reduce toxic substrate. Research will be led by Ricardo A. Feldman, Ph.D., Associate Professor, of Microbiology and Immunology in UMSOM.

Under the terms of the collaboration, UMSOM will investigate Gain’s STAR candidates in macrophage and neuronal models of nGD and GBA-associated PD. These diseases are characterized by mutations in the GBA gene, where misfolding of the enzyme encoded by GBA (beta-glucocerebrosidase (GCase)) interferes with its normal transport to the lysosome. The research program will aim to further elucidate the mechanism of action of Gain’s STAR candidates by studying their effect on GCase, including GCase’s enzyme activity and transport to the lysosome. Additionally, other effects such as prevention of alpha-synuclein aggregation in PD dopaminergic neurons will be evaluated.

“We are exceedingly proud to be advancing our work in nGD and Parkinson’s in close collaboration with the University of Maryland School of Medicine,” said Eric Richman, Chief Executive Officer at Gain. “The expertise and experience of UMSOM and Dr. Feldman will be instrumental as we work to further validate the exciting potential of Gain’s STAR candidate for these devastating diseases. I am confident these foundational studies will bring us closer to a potential new treatment option for those with these disorders.”

Dr. Feldman added, “Our laboratory has used human induced pluripotent stem cell (iPSC) models of GD and GBA-associated PD to uncover the molecular mechanisms leading to these diseases. We have also developed very sensitive assays to evaluate the therapeutic efficacy of small molecules in reversing the phenotypic abnormalities caused by mutant GBA in the cell types affected by these diseases, including macrophages and neuronal cells. I have been impressed by Gain’s initial results evaluating the potential of STARs in correcting enzyme misfolding and restoring function, and look forward to working with Gain’s team to further advance its program to treat these diseases.”

Gain and UMSOM intend to report initial data from the collaboration in the first half of 2021.

About Gain Therapeutics, Inc.
Gain Therapeutics is redefining drug discovery with its SEE-Tx™ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding. Gain was originally established in 2017 with the support of its founders and institutional investors such as TiVenture, 3B Future Health Fund (previously known as Helsinn Investment Fund) and VitaTech. It has been awarded funding support from The Michael J. Fox Foundation for

Read More
medicine

Novant Health, UNC Health, UNC School of Medicine announce agreement to partner across North Carolina

Novant Health, UNC Health and UNC School of Medicine have reached an agreement to expand medical education, research and clinical services to Novant Health facilities and other locations across North Carolina.

This partnership will expand the recently approved relationship between these organizations in New Hanover County to include Mecklenburg, Forsyth and other counties, with an additional focus to find innovative solutions to enhance care in rural areas.

The partnership will begin with locating a UNC School of Medicine branch campus at Novant Health Presbyterian Medical Center in Charlotte and will enhance and serve as an important training site for learners. It also gives more students access to learn at the best medical school for primary care in the country, according to U.S. News & World Report, and will expand the pipeline for high-quality physicians available to serve North Carolinians. In addition, the expansion of UNC School of Medicine’s Kenan Primary Care Medical Scholars Program will train more students to work in rural and under-resourced communities with enhanced training for care in those communities across North Carolina.

Additionally, clinical trials and studies from UNC School of Medicine’s world-renowned researchers will provide new treatment options for patients in Novant Health facilities.

Collaboration on population health has the potential to make a tremendous impact on the health of North Carolina. Together, through advanced analytics and proven population health strategies, more data will allow these partners to address community health challenges, such as COVID-19, opioid addiction, social determinants of health and health equity, to name a few.

“I am pleased that Forsyth and Mecklenburg counties, and the surrounding communities, will benefit from a collaboration between Novant Health and UNC Health and School of Medicine,” said Carl S. Armato, Novant Health president and CEO. “Our organizations are culturally aligned and committed to delivering safe, high-quality and affordable care while improving health equity in the communities we serve. This alignment allows us to expand access to medical education and clinical research across the state.”

“I am excited for the opportunities ahead for Novant Health, UNC Health and UNC School of Medicine to build a healthier North Carolina and to train more physicians for North Carolina,” said Dr. Wesley Burks, CEO of UNC Health and dean of UNC School of Medicine. “Our partnership will impact health in North Carolina for decades to come.”

More details will be announced as the partnership is finalized.

Source Article

Read More
medicine

Novant Health, UNC Health and UNC School of Medicine Announce Agreement to Partner Across North Carolina

WINSTON-SALEM, N.C. & CHAPEL HILL, N.C.–(BUSINESS WIRE)–Nov 19, 2020–

Novant Health, UNC Health and UNC School of Medicine have reached an agreement to expand medical education, research and clinical services to Novant Health facilities and other locations across North Carolina. This partnership will expand the recently approved relationship between these organizations in New Hanover County to include Mecklenburg, Forsyth and other counties, with an additional focus to find innovative solutions to enhance care in rural areas.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201119005675/en/

The partnership will begin with locating a UNC School of Medicine branch campus at Novant Health Presbyterian Medical Center in Charlotte and will enhance and serve as an important training site for learners. It also gives more students access to learn at the best medical school for primary care in the country, according to U . S . News & World Report, and will expand the pipeline for high-quality physicians available to serve North Carolinians. In addition, expansion of UNC School of Medicine’s Kenan Primary Care Medical Scholars Program will train more students to work in rural and under-resourced communities with enhanced training for care in those communities across North Carolina.

Additionally, clinical trials and studies from UNC School of Medicine’s world-renowned researchers will provide new treatment options for patients in Novant Health facilities.

Collaboration on population health has the potential to make a tremendous impact on the health of North Carolina. Together, through advanced analytics and proven population health strategies, more data will allow these partners to address community health challenges, such as COVID-19, opioid addiction, social determinants of health and health equity, to name a few.

“I am pleased that Forsyth and Mecklenburg counties, and the surrounding communities, will benefit from a collaboration between Novant Health and UNC Health and School of Medicine,” said Carl S. Armato, Novant Health president and CEO. “Our organizations are culturally aligned and committed to delivering safe, high-quality and affordable care, while improving health equity in the communities we serve. This alignment allows us to expand access to medical education and clinical research across the state.”

“I am excited for the opportunities ahead for Novant Health, UNC Health and UNC School of Medicine to build a healthier North Carolina and to train more physicians for North Carolina,” said Dr. Wesley Burks, CEO, UNC Health and dean of UNC School of Medicine. “Our partnership will impact health in North Carolina for decades to come.”

More details will be announced as the partnership is finalized.

About Novant Health
Novant Health is an integrated network of physician clinics, outpatient facilities and hospitals that delivers a seamless and convenient healthcare experience to communities in Virginia, North and South Carolina, and Georgia. The Novant Health network consists of more than 1,600 physicians and over 29,000 employees that provide care at nearly 700 locations, including 15 hospitals and hundreds of outpatient facilities and physician clinics. In 2020, Novant Health was the only healthcare system in North Carolina to be included on Forbes’

Read More
medicine

AccessHope and Northwestern Medicine Announce Novel Collaboration to Expand Nationwide Access to Best-in-Class Cancer Expertise

DUARTE, Calif. & CHICAGO–(BUSINESS WIRE)–On the heels of AccessHope’s national launch in October, the wholly owned subsidiary of City of Hope today announced it has joined forces with Northwestern Medicine to provide specialized cancer expertise to help more people achieve the best possible cancer outcomes. This novel collaboration brings two National Cancer Institute-designated comprehensive cancer centers together, enabling some of the country’s most sought-after specialists to offer expertise that can improve care, experience, outcomes and value for patients in the treatment of complex cancers.

“The NCI designation represents an elite group of cancer centers recognized for delivering high-quality clinical care, superior outcomes and outstanding patient experiences,” said AccessHope CEO Mark Stadler. “We’re honored to have Northwestern Medicine join City of Hope in the AccessHope program.”

The collaboration, which expands the current City of Hope network to now include experts from Northwestern Medicine, comes at a crucial time considering that COVID-19 has shown to have impacted cancer diagnosis, care and treatment. “COVID-19 has resulted in the number of cancer screenings and resulting diagnoses dropping significantly over the last several months,” noted Stadler. “AccessHope anticipates that as a result, cancer diagnoses may come later, when cancer has progressed or is at a more advanced stage, making it even more vital for individuals to receive an expert review of their case and start on the right course of treatment the first time.” City of Hope recognized the tremendous benefit to cancer patients of reimagining how they can receive the most innovative care available as close to home as possible. Demand from employers across the country led City of Hope to establish AccessHope. Today, AccessHope serves approximately 1.95 million members who have its cancer support services through 34 employers including 11 Fortune 500 companies.

AccessHope’s collaboration with Northwestern Medicine furthers its commitment to optimizing care for people facing cancer, regardless of their location. Through an employer health care benefit, employees of AccessHope clients who are diagnosed with cancer and their local treating oncologist can benefit from the expertise of specialists knowledgeable in the latest cancer discoveries for review of diagnosis, treatment plan and precision medicine opportunities, as well as clinical trial information and support services, without ever needing to leave their community.

“We believe access to the expertise we have at Northwestern Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University should not be limited by geography,” said Dean M. Harrison, president and chief executive officer, Northwestern Memorial HealthCare. “Through this collaboration, AccessHope members will benefit from the knowledge and experience of our world-class physicians and the latest in cancer research and treatment options.”

Top Ten Cancer Hospital Increases Remote Support Footprint

Northwestern Medicine is a nationally recognized health system that provides world-class compassionate care. Backed by Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern Memorial Hospital is ranked No. 8 in the nation for cancer care by U.S. News and World Report, 2020 – 2021. The Lurie Cancer Center is part of a select group of

Read More
medicine

AccessHope and Northwestern Medicine Announce Novel Collaboration to Expand Nationwide Access to Best-in-Class Cancer Expertise – Press Release

DUARTE, Calif. & CHICAGO–(Business Wire)–On the heels of AccessHope’s national launch in October, the wholly owned subsidiary of City of Hope today announced it has joined forces with Northwestern Medicine to provide specialized cancer expertise to help more people achieve the best possible cancer outcomes. This novel collaboration brings two National Cancer Institute-designated comprehensive cancer centers together, enabling some of the country’s most sought-after specialists to offer expertise that can improve care, experience, outcomes and value for patients in the treatment of complex cancers.

“The NCI designation represents an elite group of cancer centers recognized for delivering high-quality clinical care, superior outcomes and outstanding patient experiences,” said AccessHope CEO Mark Stadler. “We’re honored to have Northwestern Medicine join City of Hope in the AccessHope program.”

The collaboration, which expands the current City of Hope network to now include experts from Northwestern Medicine, comes at a crucial time considering that COVID-19 has shown to have impacted cancer diagnosis, care and treatment. “COVID-19 has resulted in the number of cancer screenings and resulting diagnoses dropping significantly over the last several months,” noted Stadler. “AccessHope anticipates that as a result, cancer diagnoses may come later, when cancer has progressed or is at a more advanced stage, making it even more vital for individuals to receive an expert review of their case and start on the right course of treatment the first time.” City of Hope recognized the tremendous benefit to cancer patients of reimagining how they can receive the most innovative care available as close to home as possible. Demand from employers across the country led City of Hope to establish AccessHope. Today, AccessHope serves approximately 1.95 million members who have its cancer support services through 34 employers including 11 Fortune 500 companies.

AccessHope’s collaboration with Northwestern Medicine furthers its commitment to optimizing care for people facing cancer, regardless of their location. Through an employer health care benefit, employees of AccessHope clients who are diagnosed with cancer and their local treating oncologist can benefit from the expertise of specialists knowledgeable in the latest cancer discoveries for review of diagnosis, treatment plan and precision medicine opportunities, as well as clinical trial information and support services, without ever needing to leave their community.

“We believe access to the expertise we have at Northwestern Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University should not be limited by geography,” said Dean M. Harrison, president and chief executive officer, Northwestern Memorial HealthCare. “Through this collaboration, AccessHope members will benefit from the knowledge and experience of our world-class physicians and the latest in cancer research and treatment options.”

Top Ten Cancer Hospital Increases Remote Support Footprint

Northwestern Medicine is a nationally recognized health system that provides world-class compassionate care. Backed by Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern Memorial Hospital is ranked No. 8 in the nation for cancer care by U.S. News and World Report, 2020 – 2021. The Lurie Cancer Center is part of a select group of NCI-designated comprehensive

Read More
medicine

Conning is Proud to Announce its Newest Focus Series-Commercial Automobile Insurance-Medicine for an Ailing Patient

HARTFORD, Conn., Nov. 16, 2020 /PRNewswire/ — Commercial automobile insurance results have been troubled for over a decade. With a combined ratio averaging 107% since 2010 and underwriting losses more than $20 billion, commercial auto is the poorest-performing commercial insurance line.

The Conning Focus Series, “Commercial Automobile Insurance–Medicine for an Ailing Patient” analyzes drivers of commercial auto’s continued underperformance and presents solutions to restore the line to health. The analysis identifies and explores root causes of commercial auto’s underperformance, some of which are underappreciated or overlooked.  Because the causes of the line’s poor results are multi-faceted, the road to recovery must be pursued on multiple fronts.

“The main tool commercial auto insurers deploy to improve results is increasing rates. Rate increases alone are not enough to get ahead of loss costs, which are often driven by liability claim inflation,” said Jerry Theodorou, a Director, Insurance Research at Conning.

“Insurers must recognize practices that inflate claims, call them out, and deal with them. Insurers that understand and address the root causes of claim inflation will be the first to get their commercial auto portfolios back to profitability,” added Steve Webersen, Head of Insurance Research.

Commercial Automobile Insurance–Medicine for an Ailing Patient” is available for purchase from Conning by calling (888) 707-1177 or by visiting www.conningresearch.com.

ABOUT CONNING
Conning (www.conning.com) is a leading investment management firm with a long history of serving the insurance industry. Conning supports institutional investors, including pension plans, with investment solutions and asset management offerings, risk modeling software, and industry research. Founded in 1912, Conning has investment centers in Asia, Europe and North America.

Media Contacts

Becky Humphrey      
Conning
860-299-2341
[email protected]

[c: 11373889] 

SOURCE Conning, Inc.

Related Links

http://www.conning.com

Source Article

Read More
medicine

Foo Fighters announce new album ‘Medicine At Midnight’ with single ‘Shame Shame’

Foo Fighters debuted a brand new single on last night’s (November 7) post-election episode of Saturday Night Live, and announced details of their 10th album.

The traditional post-election episode was once again hosted by Dave Chappelle, who toasted Joe Biden‘s victory over Donald Trump.

On the show, the Dave Grohl-led band played new track ‘Shame Shame’, which leads their new album ‘Medicine At Midnight’.

The album is set to come out on February 5, 2021. See the band debut ‘Shame Shame’, listen to its studio version, and check out the album’s tracklist and artwork below.

‘Medicine At Midnight’:

01 Making a Fire
02 Shame Shame
03 Cloudspotter
04 Waiting on a War
05 Medicine at Midnight
06 No Son of Mine
07 Holding Poison
08 Chasing Birds
09 Love Dies Young

Foo Fighters

Foo Fighters have been teasing their upcoming 10th album across this week. Yesterday, they shared a teaser of new music after eagle-eyed fans spotted the band’s ‘FF’ logo in various locations alongside an ‘X’, the Roman numeral for 10. A black-and-white clip of a burning coffin has also appeared when Spotify users play certain Foos tracks.

Foo Fighters last released a full-length record with ‘Concrete And Gold’ in 2017, and confirmed in February that they had finished recording its follow-up. Back in May, Dave Grohl likened the new album to David Bowie’s 1983 LP ‘Let’s Dance’.

“It’s filled with anthemic, huge, sing-along rock songs,” he explained. “It’s kind of like a dance record, but not an EDM, disco, modern dance record. It’s got groove. To me, it’s our David Bowie’s ‘Let’s Dance’ record. That’s what we wanted to make, we wanted to make this really up, fun record.”

Source Article

Read More
medicine

Foo Fighters Release ‘Shame Shame,’ Announce New Album Medicine at Midnight

Click here to read the full article on SPIN.

After a week of teasing activity. Foo Fighters debuted their new single “Shame Shame” on Saturday Night Live. The song is off the band’s 10th album, which is titled Medicine at Midnight, which is slated to be released on Feb. 5, 2021. The album is produced by Greg Kurstin and Foo Fighters. The band’s last album, Concrete and Gold, was released in 2017.

“Shame Shame” is available to stream now, listen to the studio version below.

More from SPIN:

It was supposed to be a busy year for Dave Grohl and company. Grohl told Bill Simmons earlier this year that the band’s album was done and that he planned on releasing a documentary as well. Foo Fighters were slated to hit the road for a string of dates in support of their 25th anniversary, however, the pandemic changed those plans. Grohl reflected on the band’s anniversary in July and being Nirvana’s “fifth drummer.”

Last week, the band shared a goofy spoof commercial mocking Grohl’s addiction to coffee and they also appeared at a virtual show in support of Joe Biden, performing “Times Like These.” They also released the Live on the Radio 1996 EP last month. The release followed the launch of the band’s People of Rock and Roll digital zine. And don’t forget that Grohl is in an ongoing musical battle with drumming prodigy, Nandi Bushell.

Preorder the album here. Check out the tracklisting for Medicine at Midnight below:

Making a Fire
Shame Shame
Cloudspotter
Waiting on a War
Medicine at Midnight
No Son of Mine
Holding Poison
Chasing Birds
Love Dies Young

To see our running list of the top 100 greatest guitarists of all time, click here.

Source Article

Read More